Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignace Vergote

Showing results (231-240 of 578) with videos related to

Pageof 58
Sort By:
Gynecologic Oncology|September 29, 2012
Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance -- a study of the OVCAD consortiumEva Obermayr, Dan Cacsire Castillo-Tong, Dietmar Pils, et al.
Anticancer Research|May 6, 2009
The use of laser microdissection and SELDI-TOF MS in ovarian cancer tissue to identify protein profilesIsabelle Cadron, Toon Van Gorp, Frederic Amant, et al.
BMC Cancer|February 7, 2014
Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO)Kristina Lindemann, Susanne Malander, Rene D Christensen, et al.
Cancers|April 12, 2022
Biomarker-Based Models for Preoperative Assessment of Adnexal Mass: A Multicenter Validation StudyRafał Watrowski, Eva Obermayr, Christine Wallisch, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 15, 2020
European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and industry partners - a new Model D for drug and medical device developmentNicole Concin, Isabelle Ray-Coquard, Rosalind M Glasspool, et al.
Cancer|June 7, 2005
Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma: a prospectively planned combined survival analysis of two multicenter trialsAnthony Howell, John Pippen, Richard M Elledge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA TrialAndres M Poveda, Frédéric Selle, Felix Hilpert, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 15, 2022
Best original research presented at the 23rd European Congress on Gynaecological Oncology-Best of ESGO 2022Joanna Kacperczyk-Bartnik, Nicolò Bizzarri, Martina Aida Angeles, et al.
Journal of the National Cancer Institute|April 8, 2020
A Systematic Review of Estimating Breast Cancer Recurrence at the Population Level With Administrative DataHava Izci, Tim Tambuyzer, Krizia Tuand, et al.
Journal of Physiotherapy|September 23, 2018
Manual lymph drainage may not have a preventive effect on the development of breast cancer-related lymphoedema in the long term: a randomised trialNele Devoogdt, Inge Geraerts, Marijke Van Kampen, et al.
Pageof 58

Showing results (231-240 of 578) with videos related to

Sort By:
Pageof 58
Gynecologic Oncology|September 29, 2012
Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance -- a study of the OVCAD consortiumEva Obermayr, Dan Cacsire Castillo-Tong, Dietmar Pils, et al.
Anticancer Research|May 6, 2009
The use of laser microdissection and SELDI-TOF MS in ovarian cancer tissue to identify protein profilesIsabelle Cadron, Toon Van Gorp, Frederic Amant, et al.
BMC Cancer|February 7, 2014
Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO)Kristina Lindemann, Susanne Malander, Rene D Christensen, et al.
Cancers|April 12, 2022
Biomarker-Based Models for Preoperative Assessment of Adnexal Mass: A Multicenter Validation StudyRafał Watrowski, Eva Obermayr, Christine Wallisch, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 15, 2020
European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and industry partners - a new Model D for drug and medical device developmentNicole Concin, Isabelle Ray-Coquard, Rosalind M Glasspool, et al.
Cancer|June 7, 2005
Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma: a prospectively planned combined survival analysis of two multicenter trialsAnthony Howell, John Pippen, Richard M Elledge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA TrialAndres M Poveda, Frédéric Selle, Felix Hilpert, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 15, 2022
Best original research presented at the 23rd European Congress on Gynaecological Oncology-Best of ESGO 2022Joanna Kacperczyk-Bartnik, Nicolò Bizzarri, Martina Aida Angeles, et al.
Journal of the National Cancer Institute|April 8, 2020
A Systematic Review of Estimating Breast Cancer Recurrence at the Population Level With Administrative DataHava Izci, Tim Tambuyzer, Krizia Tuand, et al.
Journal of Physiotherapy|September 23, 2018
Manual lymph drainage may not have a preventive effect on the development of breast cancer-related lymphoedema in the long term: a randomised trialNele Devoogdt, Inge Geraerts, Marijke Van Kampen, et al.
Pageof 58